Form 8K Kenvue Inc For: 2 November
- Investing.com
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Kenvue Inc (KVUE)
Track today's live Kenvue (KVUE) share price, performance and key data on this page with our current Vienna:KVUE stock exchange information. Analyse interactive charts and historical data, check technical buy and sell signals in real time, and follow the Kenvue share price on the Vienna exchange. Use the dropdown to switch exchange for the KVUE share price, head to our technical summary section, which provides analysis on Kenvue share price buy/sell indicators using real-time data (or discuss the Kenvue (KVUE) stock price today with other investors in the Kenvue VIE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current VIE:KVUE share price (ISIN: US49177J1025) to enhance your trading decisions with our free investment tools and resources.
What Is the Kenvue Inc Share Price Today?
The Kenvue share price today is 17.42.
What Is the Stock Symbol for Kenvue Inc
The stock symbol (or 'ticker') for Kenvue Inc is "KVUE."
What Stock Exchange Does Kenvue Inc Trade On?
Kenvue Inc is listed and trades on the Vienna stock exchange.
Is Kenvue Inc a Good Stock to Buy?
Determining whether Kenvue (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Use the dropdown to select a relevant stock exchange for the current VIE:KVUE share price (ISIN: US49177J1025) to enhance your trading decisions with our free investment tools and resources.
What Is the Kenvue Inc Share Price Today?
The Kenvue share price today is 17.42.
What Is the Stock Symbol for Kenvue Inc
The stock symbol (or 'ticker') for Kenvue Inc is "KVUE."
What Stock Exchange Does Kenvue Inc Trade On?
Kenvue Inc is listed and trades on the Vienna stock exchange.
Is Kenvue Inc a Good Stock to Buy?
Determining whether Kenvue (or any stock) is a good buy requires comprehensive market analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and more than 1,200 other metrics.
Vienna
Currency in EUR
17.42
0.00(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.30
17.83
52 wk Range
15.38
17.83
Trading near 52-week High
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
17.3017.83
52 wk Range
15.3817.83
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
KVUE Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in overbought territory
Kimberly-Clark completes acquisition of Kenvue- Investing.com
Kimberly-Clark completes acquisition of Kenvue- Investing.com
Pro
- Form 8K Kenvue Inc For: 2 November
- Investing.com
- Kimberly-Clark completes acquisition of Kenvue
- Investing.com
- Kimberly-Clark completes acquisition of Kenvue
- Investing.com
Pro 
Kenvue Inc receives Investment Bank Analyst Rating Update- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Buy
Moving Averages
Buy
Earnings
Latest Release
30/10/2026
EPS / Forecast
0.22 / --
Revenue / Forecast
3.89B / --
Compare KVUE to Peers and Sector
Metrics to compare | KVUE | Sector Sector - Average of metrics from a broad group of related Consumer Non-Cyclicals sector companies | Relationship RelationshipKVUEPeersSector | |
|---|---|---|---|---|
P/E Ratio | 22.0x | 24.8x | 10.8x | |
PEG Ratio | 1.24 | −0.07 | 0.03 | |
Price/Book | 3.7x | 5.9x | 1.5x | |
Price / LTM Sales | 2.4x | 2.5x | 0.8x | |
Upside (Analyst Target) | - | −3.2% | 22.6% | |
Fair Value Upside | Unlock | 11.0% | 14.0% | Unlock |
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women’s health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee’s Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson’s, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson’s Baby, Johnson’s Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. The company was formerly known as JNTL, Inc. and changed its name to Kenvue Inc. in August 2022. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey. As of November 2, 2026, Kenvue Inc. operates as a subsidiary of Kimberly-Clark Corporation.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Kenvue (Vienna: KVUE) Share Price Today?
The Kenvue stock price today is 17.42 EUR.
What Stock Exchange Does Kenvue (KVUE) Trade On?
Kenvue is listed and trades on the Vienna Stock Exchange.
What Is the Ticker (Stock Symbol) for Kenvue?
The stock symbol (also called a 'ticker') for Kenvue is "KVUE."
What Is the Current Kenvue Market Capitalisation?
As of today, Kenvue (Vienna: KVUE) market cap is 33.16B EUR.
What Is Kenvue's (KVUE) Earnings Per Share (TTM)?
The Kenvue EPS is currently 0.77 (Trailing Twelve Months).
Is KVUE a Buy or Sell From a Technical Analyst Perspective?
Based on today's Kenvue moving averages and other technical indicators, the daily buy/sell signal for KVUE stock is Buy.
How Many Times Has Kenvue Stock Split?
Kenvue has split 0 times. (See the KVUE stock split history page for full effective split date and price information.)
How Many Employees Does Kenvue Have?
Kenvue has 21890 employees, based on their latest Companies House report.
What is the current trading status of Kenvue (Vienna: KVUE)?
As of 14/11/2026, Kenvue (KVUE) is trading at a share price of 17.42 EUR, with a previous close of 17.42 EUR. The stock has fluctuated within a day range of 17.30 EUR to 17.83 EUR, while its 52-week range spans from 15.38 EUR to 17.83 EUR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.